Sutro Biopharma Inc
STRO
Market Cap$235.41M
Close$
$5.81
54.2% upside
Current Fair Value
54.2% upsideUndervalued by 54.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $235.41 Million |
|---|---|
| Enterprise Value | $-106,576,799.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.78 |
| Beta | 1.28 |
| Outstanding Shares | 62,441,963 |
| Avg 30 Day Volume | 1,468,990 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.2 |
|---|---|
| PEG | 1.16 |
| Price to Sales | 1.89 |
| Price to Book Ratio | 1.89 |
| Enterprise Value to Revenue | -0.69 |
| Enterprise Value to EBIT | 1.19 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.32 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
ESG Score
No data
About Sutro Biopharma Inc
CEO: William Newell